Sarafem (Fluoxetine Hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 4, 2021 Category: Drugs & Pharmacology Source Type: news
Years of Prozac Alter Lipids in Young Monkeys ’ Brains: Study
Long-term administration of the antidepressant fluoxetine was tied to decreased concentrations of about 100 different brain lipids in adolescent macaques, hinting at a potential mechanism underlying... (Source: The Scientist)
Source: The Scientist - September 10, 2021 Category: Science Tags: News & Opinion Source Type: news
Final Word on SSRI for Post-Stroke Depression? Final Word on SSRI for Post-Stroke Depression?
The antidepressant fluoxetine does not prevent or alleviate post-stroke depression, new findings from a randomized, placebo-controlled trial confirm.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 12, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Prenatal exposure to THC, CBD affects offspring's responsiveness to fluoxetine
(Indiana University) Scientists have found that significant amounts of the two main components of cannabis, THC and CBD, enter the embryonic brain of mice in utero and impair the mice's ability as adults to respond to fluoxetine, a drug commonly known by the brand name Prozac. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 1, 2021 Category: International Medicine & Public Health Source Type: news
Dash Xclusive Issues Voluntary Nationwide Recall of Imperia Elita Vitaccino Coffee Due to the Presence of Undeclared Sibutramine and Fluoxetine
Dash Xclusive is voluntarily recalling all lots of Imperia Elita Vitaccino Coffee to the consumer level. FDA analysis has found the product to contain undeclared sibutramine and fluoxetine. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 28, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Una revoluci ón psicodélica llega a la psiquiatría
La psilocibina y el MDMA est án a punto de convertirse en las nuevas terapias de moda, algo que no se veía desde el Prozac. Las universidades quieren participar, al igual que Wall Street. Algunas personas están preocupadas por la posibilidad de que la presión para liberalizar el acceso pueda tener consecuencias no deseadas. (Source: NYT Health)
Source: NYT Health - May 15, 2021 Category: Consumer Health News Authors: Andrew Jacobs Tags: Psilocybin Mushrooms LSD (Lysergic Acid Diethylamide) Ecstasy (Drug) Anxiety and Stress Mental Health and Disorders Venture Capital Depression (Mental) Research Alternative and Complementary Medicine Psychiatry and Psychiatrists Post-T Source Type: news
Author Q & A: New generation antidepressants for depression in children and adolescents
In this author interview we find out more about this recently published Network Meta-analysis,New generation antidepressants for depression in children and adolescents. Authors Dr. Sarah Hetrick and Nick Meader tell us about this work.What were you trying to find out with this Network Meta-Analysis?We were trying to find out how well newer generation antidepressants work compared with placebo and if some are more effective than others. We wanted to know how these antidepressants affect:symptoms of depression;recovery: no longer meeting diagnostic criteria for major depressive disorder;response or remission: scores on a sca...
Source: Cochrane News and Events - May 11, 2021 Category: Information Technology Authors: Rachel Klabunde Source Type: news
How MDMA and Psilocybin Became Hot Investments
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences. (Source: NYT Health)
Source: NYT Health - May 10, 2021 Category: Consumer Health News Authors: Andrew Jacobs Tags: Psilocybin Mushrooms LSD (Lysergic Acid Diethylamide) Ecstasy (Drug) Anxiety and Stress Mental Health and Disorders Venture Capital Depression (Mental) Research Alternative and Complementary Medicine Psychiatry and Psychiatrists Post-T Source Type: news
Trajectories of change in depression symptoms and suicidal ideation over the course of evidence-based treatment for depression: secondary analysis of a randomised controlled trial of cognitive behavioural therapy plus fluoxetine in young people - Witt K, Madsen T, Berk M, Dean O, Chanen A, McGorry PD, Cotton S, Davey CG, Hetrick S.
OBJECTIVES: Effective treatment of depression is a key target for suicide prevention strategies. However, only around one-third of young people with suicide risk respond to evidence-based treatments. Understanding the trajectory of suicidal ideation, as a ... (Source: SafetyLit)
Source: SafetyLit - March 19, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Serious Shortage Protocols for fluoxetine 30mg capsules and Salazopyrin EN-Tabs 500mg
The Department of Health and Social Care (DHSC) has issued Serious Shortage Protocols (SSP) for fluoxetine 30mg capsules and Salazopyrin® EN-Tabs 500mg.
The fluoxetine 30mg capsules SSP will ena (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 21, 2020 Category: Drugs & Pharmacology Source Type: news
Why Do People Take Prozac?
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 2, 2020 Category: General Medicine Source Type: news
